Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

Clinical trial NCT06107374 · RECRUITING

Trial details

NCT number: NCT06107374
Sponsor: CellSight Technologies, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non Small Cell Lung Cancer

Start date: 2023-11-01
Primary completion: 2025-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.